Type I IFN immunoprofiling in COVID-19 patients

Trouillet‐Assant, Sophie; Viel, Sébastien; Gaymard, Alexandre; Pons, Sylvie; Richard, Jean‐Christophe; Perret, Magali; Villard, Marine; Brengel‐Pesce, Karen; Lina, Bruno; Mezidi, Mehdi; Bitker, Laurent; Bélot, Alexandre; Mouton, William; Oriol, Guy; Compagnon, Christelle; Generenaz, Laurence; Cheynet, Valérie; Ader, Florence; Becker, Agathe; Benech, Nicholas; Chauvelot, Pierre; Chidiac, Christian; Conrad, Anne; Ferry, Tristan; Miailhes, Patrick; Perpoint, Thomas; Perry, Marielle; Pouderoux, Cécile; Roux, Sandrine; Triffault-Fillit, Claire; Valour, Florent; Hodane, Yonis; Chauvelot, Louis; Chabert, Paul; Provoost, Judith; David, Guillaume; Folliet, Laure; Lecam, Pierre; Billaud, Geneviève; Bouscambert, Maude; Escuret, Vanessa; Frobert, Émilie; Bal, Antonin; Destras, Grégory; Josset, Laurence; Morfin, Florence; Munier, Clément; Valette, Martine; Venet, Fabienne; Garnier, Lorna; Pescarmona, Rémi; Lombard, Christine; Walzer, Thierry

doi:10.1016/j.jaci.2020.04.029

Public

Type I IFN immunoprofiling in COVID-19 patients

Published in Journal of Allergy and Clinical Immunology • Apr 29, 2020

Authors:

Sophie Trouillet‐Assant

Sébastien Viel

Alexandre Gaymard

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which causes coronavirus disease 2019 (COVID-19), is characterized by a wide spectrum of disease encompassing asymptomatic carriage, mild to severe upper respiratory tract illness that can evolve into respiratory failure, or rap...

Subject

Cytokine storm

Medicine

Immunology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!